Page last updated: 2024-08-23

epirubicin and Myelodysplastic Syndromes

epirubicin has been researched along with Myelodysplastic Syndromes in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alimonti, A; Carlini, P; Cognetti, F; Di Cosimo, S; Fabi, A; Ferretti, G; Nardoni, C; Papaldo, P; Ruggeri, EM1
Bergh, J; Bliss, J; Bonneterre, J; Cesana, B; Coombes, RC; Fargeot, P; Folin, A; Fumoleau, P; Giuliani, R; Hery, M; Kerbrat, P; Nilsson, J; Onida, F; Piccart, M; Praga, C; Rogers, D; Shepherd, L; Therasse, P; Wils, J1
Ferretti, G; Papaldo, P1
Arbona, C; Benet, I; Comes, AM; García Clavel, B; García-Conde, J; Lluch, A; Martínez-Climent, JA; Marugán, I; Prósper, F; Solano, C; Vizcarra, E1

Trials

1 trial(s) available for epirubicin and Myelodysplastic Syndromes

ArticleYear
Does the concurrent use of anthracycline and granulocyte colony-stimulating factor influence the risk of secondary leukaemia in breast cancer women?
    Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:7

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Risk Factors

2005

Other Studies

3 other study(ies) available for epirubicin and Myelodysplastic Syndromes

ArticleYear
Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jun-20, Volume: 23, Issue:18

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Data Interpretation, Statistical; Epirubicin; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Middle Aged; Myelodysplastic Syndromes; Randomized Controlled Trials as Topic; Risk Factors

2005
Acute myeloid leukaemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Breast cancer research and treatment, 2008, Volume: 109, Issue:1

    Topics: Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Proportional Hazards Models; Treatment Outcome

2008
Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.
    Bone marrow transplantation, 2000, Volume: 25, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Chemotherapy, Adjuvant; Chromosome Aberrations; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Middle Aged; Myelodysplastic Syndromes; Neoplasm Staging; Neoplasms, Second Primary; Postmenopause; Predictive Value of Tests; Premenopause; Transplantation, Autologous

2000